Search for: "Mylan LLC" Results 1 - 20 of 265
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Apr 2024, 4:52 am by Erica Blachman Hitchings
  For example, Mylan and Mallinckrodt settled significant cases alleging Medicaid rebate fraud brought by our whistleblower clients. [read post]
17 Oct 2023, 3:40 pm by Rik Lambers (Brinkhof)
– – – – – – – – – – – [1] At least, as to foreign judgments, this was considered in PI proceedings in DC Amsterdam 6 January 2023, DIVX/Netlfix, and confirmed in this decision. [2] In particular in view of CoA The Hague 15 August 2023, BMS/Sandoz (Apixaban). [3] Warner-Lambert Company LLC (Respondent) v Generics (UK) Ltd v, Mylan and another (Appellants) [2018] UKSC 56. [read post]
16 May 2023, 10:50 am by Kelly Shivery
 Among the firm’s many successes are the Mallinckrodt and Mylan cases discussed above. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
23 Jan 2023, 10:40 am by David W.S. Lieberman
In October 2022, the United States settled our case against DermaTran Health Solutions, LLC, its parent State Mutual Insurance Company, President Delos Yancey, and other defendants. [read post]
7 Dec 2022, 8:00 am by Linda C. Severin
Since 2003, she has represented whistleblower clients including in several record-breaking cases such as settlements with Amgen, AmerisourceBergen Corporation, and Mylan. [read post]
3 Oct 2022, 8:27 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
16 Sep 2022, 6:15 am by Kelly Shivery
For more information, contact the Whistleblower Law Collaborative LLC at 617.366.2800. [read post]
18 Aug 2022, 4:43 am by Melissa Tremblay
Erica Blachman Hitchings Whistleblower LLC Member Erica Blachman Hitchings was recognized for Best Lawyers 2023 Employment Law – Individuals. [read post]
7 Jul 2022, 7:15 am by David Hemming (Bristows)
Continuing, he also noted that in Warner-Lambert Co LLC v Generics (UK) Ltd (t/a Mylan) [2018] UKSC 56, the Supreme Court “upheld the distinction drawn between amendments to delete claims that have been held to be invalid and amendments designed to make good a claim not thus far advanced in the amended form”, in other words confirming that what the Court of Appeal had said in IPCom and Nikken was correct. [read post]
16 Jun 2022, 4:02 pm by Linda C. Severin
In 2017, Mylan paid $465 million for misclassifying EpiPen® as a generic drug to avoid paying the higher rebates owed on brand name drugs. [read post]
28 Mar 2022, 7:13 am by Linda C. Severin
Landolt came to us with his concerns, we immediately recognized the significance of this matter because our firm had handled the Mylan EpiPen rebate case,” Severin said, referring to a 2016 case where Mylan paid $465 million for misclassifying the emergency allergy EpiPen shot as a generic drug to avoid paying the higher rebates. [read post]